FIGOPAR
EACH ML CONTAINS:HEPARIN SODIUM USP 5000 IU/ML(DERIVED FROM BOVINE MUCOSA), BENZYL ALCOHOL USP 0.95%W/V, WATER FOR INJECTION USP Q.S
What it does
Alcohol is a substance that can affect your mood and behavior. It is important to use it carefully, especially if you are taking other medications.
Commonly used for: social enjoyment, anxiety relief, temporary relaxation
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.
Source this medicineRegistration & product details
Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:05:16 · updated 2026-07-26 13:47:38
Drug Interactions
8Pharmacodynamic Warnings
Alcohol appears in TABLE 1: Drugs that cause hepatotoxicity
Alcohol appears in TABLE 8: Drugs that cause hypotension
Alcohol appears in TABLE 11: Drugs with CNS depressant effects
Unknown (8)
Acitretin - increases concentration
Alcohol potentially increases the concentration of retinoids (acitretin). Avoid and for 2 months after stopping acitretin.
Antiepileptics - increases risk of visual disturbances
Alcohol potentially increases the risk of visual disturbances when given with antiepileptics (retigabine).
Methylphenidate - increases concentration
Alcoholmightincreasetheconcentrationofmethylphenidate. Avoid.oStudy
Retigabine - increases risk of visual disturbances
Alcohol potentially increases the risk of visual disturbances when given with antiepileptics (retigabine).
Retinoids - increases concentration
Alcohol potentially increases the concentration of retinoids (acitretin). Avoid and for 2 months after stopping acitretin.
Topical Pimecrolimus - increases risk of facial flushing and skin irritation
Alcohol increases the risk of facial flushing and skin irritation when given with topical pimecrolimus.
Topical Tacrolimus - increases risk of facial flushing and skin irritation
Alcohol increases the risk of facial flushing and skin irritation when given with topical tacrolimus.
Vasopressin - decreases antidiuretic effect
Alcoholmightdecreasetheantidiureticeffectofvasopressin. oTheoretical Aldesleukin →seeTABLE15p.1520(myelosuppression) Alectinib →seeTABLE6p.1518(bradycardia),TABLE1p.1517 (hepatotoxicity) com/codemedic
Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: exact
About alcohol
Alcohol is a substance that can affect your mood and behavior. It is important to use it carefully, especially if you are taking other medications.
What it treats
- social enjoyment
- anxiety relief
- temporary relaxation
How it works
Alcohol affects the brain and central nervous system, leading to changes in mood and behavior.
Who it's for
Adults who consume alcohol in moderation for social or relaxation purposes.
Cautions
- • Be cautious if taking medications that can harm the liver.
- • Use with care if you have low blood pressure.
- • Avoid combining with medications that can cause drowsiness.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
About benzyl
Benzyl is an ingredient used in various treatments, often in topical formulations.
What it treats
- skin infections
- eczema
- scabies
How it works
Benzyl helps to kill bacteria or parasites on the skin, promoting healing.
Who it's for
This treatment is for individuals with skin conditions requiring antibacterial or antiparasitic action.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: Alcohol
BNF-referencedAlcohol is a volatile, flammable liquid used primarily as an antiseptic for skin disinfection and preparation before injections. It is commonly employed in medical settings to cleanse the skin and reduce the risk of infection.
Indications
- Skin disinfection
- Preparation of skin before injections
- Cleansing minor wounds
Dosage
Children: Apply to the skin as required; consult product literature for specific guidance.
Adults: Apply to the skin as required for disinfection.
Mechanism of action
Alcohol exerts its antiseptic effect by denaturing proteins, disrupting cell membranes, and dehydrating microbial cells, leading to cell lysis and death.
Pharmacodynamics
Alcohol has broad-spectrum antimicrobial activity, effective against bacteria, fungi, and viruses. Its efficacy is influenced by concentration, with higher concentrations generally being more effective.
Pharmacokinetics
Alcohol is rapidly absorbed through the skin and mucous membranes. It is metabolized primarily in the liver, with a half-life that varies based on the individual's metabolic rate and the amount consumed.
Contra-indications
- Concomitant use with lithium
- Regular use in neonates
- Patients with severe burns when diathermy has been preceded by application of alcoholic skin disinfectants
Adverse effects
- Eye erythema
- Punctate keratitis
- Cytotoxicity
- Eye discolouration
Interactions
- Increases risk of visual disturbances with antiepileptics
- Increases concentration with methylphenidate
- Increases risk of facial flushing and skin irritation with topical pimecrolimus
- Increases concentration with retinoids
- Increases concentration with acitretin
- Increases risk of facial flushing and skin irritation with topical tacrolimus
- Decreases antidiuretic effect with vasopressin
Precautions
- Avoid regular application to inflamed or broken skin or mucosa
- Avoid broken skin
- Flammable
Pregnancy
Sufficient iodine may be absorbed to affect the fetal thyroid in the second and third trimester.
Breast-feeding
Avoid regular or excessive use.
Storage
Store in a cool, dry place away from heat and direct sunlight.
Formulations
- Betadine 2.5% dry powder spray
- Industrial methylated spirit
- Povidone-Iodine 25 mg per 1 gram
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Clinical monograph: benzyl
BNF-referencedBenzylpenicillin, a member of the penicillin class of antibiotics, is primarily used to treat infections caused by susceptible microorganisms. It is effective against a range of Gram-positive bacteria and some Gram-negative bacteria, making it a valuable agent in the treatment of various infections, including pneumonia, meningitis, and syphilis.
Indications
- Bacterial infections
- Pneumonia
- Meningitis
- Syphilis
- Endocarditis
- Skin and soft tissue infections
Dosage
Children: Paediatric dosing for benzylpenicillin is determined by the child's weight and the severity of the infection. Refer to the BNF for Children for specific dosing guidelines.
Adults: The usual adult dose for benzylpenicillin varies based on the type and severity of the infection. It is generally administered via intramuscular or intravenous routes. For severe infections, doses may range from 1 to 4 million units every 4 to 6 hours.
Mechanism of action
Benzylpenicillin exerts its antibacterial effects by inhibiting the synthesis of bacterial cell walls. It binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, disrupting the transpeptidation process, which is crucial for cross-linking peptidoglycan layers. This inhibition leads to cell lysis and death of the bacteria.
Pharmacodynamics
Benzylpenicillin demonstrates time-dependent bactericidal activity, meaning its effectiveness is related to the duration of time the drug concentration remains above the minimum inhibitory concentration (MIC) for the target bacteria. It has a narrow spectrum of activity, primarily targeting Gram-positive cocci and some Gram-negative rods.
Pharmacokinetics
Benzylpenicillin is typically administered parenterally due to poor oral absorption. It is rapidly distributed throughout the body and can penetrate various tissues, including the central nervous system during inflammation. The drug is primarily eliminated by renal excretion, with a half-life of approximately 30 minutes to 1 hour in healthy individuals. Dosage adjustments may be necessary in patients with renal impairment.
Interactions
- leflunomide+benzylpenicillin: Unknown (increases exposure)
- nitisinone+benzylpenicillin: Unknown (increases exposure)
- teriflunomide+benzylpenicillin: Unknown (increases exposure)
Pregnancy
Benzylpenicillin is generally considered safe to use during pregnancy, as it is a penicillin antibiotic and has a long history of use.
Breast-feeding
Benzylpenicillin is excreted in breast milk in small amounts, but it is not expected to have adverse effects on a nursing infant.
Storage
Store in a cool, dry place, protected from light. Reconstituted solutions should be used promptly or stored in a refrigerator and used within a limited time frame.
Formulations
- Benzylpenicillin injection
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
Molecular reference: Alcohol
PubChem CID 702Molecular formula: C2H6O
Mechanism of action
Ethanol affects the brain’s neurons in several ways. It alters their membranes as well as their ion channels, enzymes, and receptors. Alcohol also binds directly to the receptors for acetylcholine, serotonin, GABA, and the NMDA receptors for glutamate. The sedative effects of ethanol are mediated through binding to GABA receptors and glycine receptors (alpha 1 and alpha 2 subunits). It also inhibits NMDA receptor functioning. In its role as an anti-infective, ethanol acts as an osmolyte or dehydrating agent that disrupts the osmotic balance across cell membranes. ... Ethanol is known to affect a large number of membrane proteins that participate in signaling pathways such as neurotransmitter receptors, enzymes, and ion channels, and there is extensive evidence that ethanol interacts with a variety of neurotransmitters. The major actions of ethanol involve enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) at GABAa receptors and blockade of the N-methyl-D-aspartate (NMDA) subtype of glutamate, an excitatory amine acid (EAA) receptor. Animal studies indicate that the acute effects of ethanol result from competitive inhibition of glycine binding to NMDA receptor and disruption of glutamatergic neurotransmission by inhibiting the response of the NMDA receptor. Persistent glycine antagonism and attenuation of glutamatergic neurotransmission by chronic ethanol exposure results in tolerance to ethanol by enhancing EAA neurotransmission and NMDA receptor upregulation. The latter appears to involve selective increases in NMDA R2B subunit concentrations and other molecular changes in specific brain loci. The abrupt withdrawal of ethanol thus produces a hyperexcitable state that leads to the ethanol withdrawal syndrome and excitotoxic neuronal death. GABA-mediated inhibition, which normally acts to limit excitation, is eliminated during ethanol withdrawal syndrome and further intensifies this excitation. In addition, NMDA receptors function to inhibit the release of dopamine in the nucleus accumbens and mesolimbic structures, which modulate the reinforcing action of addictive xenobiotics such as ethanol. By inhibiting NMDA receptor activity, ethanol could increase dopamine release from the nucleus accumbens and ventral tegmental area and could thus create dependence. Chronic ethanol administration also results in tolerance, dependence, and an ethanol withdrawal syndrome, mediated, in part, by desensitization and or downregulation of GABAa receptors. The development of alcoholic ketoacidosis (AKA) requires that a combination of physical and physiologic events occur. The normal response to starvation and depletion of hepatic glycogen stores is for amino acids to be converted to pyruvate. Pyruvate can serve as a substrate for gluconeogenesis, be converted to acetyl-CoA, which can enter the Krebs cycle or can be utilized in various biosynthetic pathways (eg, fatty acid, ketone bodies, cholesterol, and acetylcholine) ... Ethanol metabolism generates NADH, resulting in an excess of reducing potential. This high redox state favors the conversion of pyruvate to lactate, diverting pyruvate from being a substrate for gluconeogenesis. To compensate for the lack of normal metabolic substrates, the body mobilizes fat from adipose tissue and increased fatty acid metabolism as an alternative source of energy. This response is mediated by a decrease in insulin and an increased secretion of glucagon, catecholamines, growth hormone, and cortisol. Fatty acid metabolism results in the formation of acetyl-CoA and it combines with the excess acetate that is generated from ethanol metabolism to form acetoacetate. Most of the acetoacetate is reduced to beta-hydroxybutyrate due to the excess reducing potential or high redox state of the cell. Volume depletion interferes with the renal elimination of acetoacetate and beta-hydroxybutyrate, and contributes to the acidosis. An elevated lactate concentration may result from shunting from pyruvate or
Pharmacodynamics
Alcohol produces injury to cells by dehydration and precipitation of the cytoplasm or protoplasm. This accounts for its bacteriocidal and antifungal action. When alcohol is injected in close proximity to nerve tissues, it produces neuritis and nerve degeneration (neurolysis). Ninety to 98% of ethanol that enters the body is completely oxidized. Ethanol is also used as a cosolvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations. Ethanol also binds to GABA, glycine, NMDA receptors and modulates their effects. Ethanol is also metabolised by the hepatic enzyme alcohol dehydrogenase.
Biological pathways
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
Molecular reference: benzyl
PubChem CID 123147Molecular formula: C7H7
Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.
- ASHIVER INJECTION (Each ml containns Ivermectin 10mg/ Benzyl Alchohol 1.5% v/v) · Ashish Life Science
- AVICINOR ORAL SOLUTION · Hebei Kexing Pharmaceutical
- AVICINOR ORAL SOLUTION (Each ml conatins Gluteraldehyde/Coco-dimethyl benzyl ammonium chloride 300mg/200mg) · Hebei Kexing Pharmaceutical
- AVICINOR ORAL SOLUTION (Each ml contains Gluteraldehyde 50% 300mg/ Coco-dimethyl benzyl ammonium chloride 50% 200mg) · Hebei Kexing Pharmaceutical
- BENZYL BENZOATE · Micron Pharmaceuticals
- BENZYL BENZOATE CUTANEOUS EMULSION · Darwin Aryton Starwin